Stay updated on Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.

Latest updates to the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page
- Check6 days agoNo Change Detected
- Check12 days agoChange DetectedThe record describes a completed Phase 4 study of mepolizumab for Indian adults with severe eosinophilic asthma, including its treatment plan, participant criteria, and measured outcomes. It also provides study results resources and information about sharing participant data.SummaryDifference58%

- Check20 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check27 days agoChange DetectedA notice was added above the study record stating that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and linking to related updates and FAQs.SummaryDifference1%

- Check34 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 error.SummaryDifference0.2%

- Check55 days agoChange DetectedNo additions or deletions were reported for this page. The page currently displays a 403 Forbidden error, indicating access is restricted.SummaryDifference0.2%

Stay in the know with updates to Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.